Seo AN - Search Results

1

Low prognostic implication of fibroblast growth factor family activation in triple-negative breast cancer subsets.

Lee HJ, Seo AN, Park SY, Kim JY, Park JY, Yu JH, Ahn JH, Gong G. Lee HJ, et al. Among authors: seo an. Ann Surg Oncol. 2014 May;21(5):1561-8. doi: 10.1245/s10434-013-3456-x. Epub 2014 Jan 3. Ann Surg Oncol. 2014. PMID: 24385208

2

BRAFV600E mutation does not serve as a prognostic factor in Korean patients with papillary thyroid carcinoma.

Ahn D, Park JS, Sohn JH, Kim JH, Park SK, Seo AN, Park JY. Ahn D, et al. Among authors: seo an. Auris Nasus Larynx. 2012 Apr;39(2):198-203. doi: 10.1016/j.anl.2011.07.011. Epub 2011 Aug 20. Auris Nasus Larynx. 2012. PMID: 21862261

3

Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer.

Seo AN, Lee HJ, Kim EJ, Kim HJ, Jang MH, Lee HE, Kim YJ, Kim JH, Park SY. Seo AN, et al. Br J Cancer. 2013 Nov 12;109(10):2705-13. doi: 10.1038/bjc.2013.634. Epub 2013 Oct 15. Br J Cancer. 2013. PMID: 24129232 Free PMC article.

4

MET gene copy number gain is an independent poor prognostic marker in Korean stage I lung adenocarcinomas.

Jin Y, Sun PL, Kim H, Seo AN, Jheon S, Lee CT, Chung JH. Jin Y, et al. Among authors: seo an. Ann Surg Oncol. 2014 Feb;21(2):621-8. doi: 10.1245/s10434-013-3355-1. Epub 2013 Nov 9. Ann Surg Oncol. 2014. PMID: 24212721

5

Two histopathologically different diseases: hormone receptor-positive and hormone receptor-negative tumors in HER2-positive breast cancer.

Lee HJ, Park IA, Park SY, Seo AN, Lim B, Chai Y, Song IH, Kim NE, Kim JY, Yu JH, Ahn JH, Gong G. Lee HJ, et al. Among authors: seo an. Breast Cancer Res Treat. 2014 Jun;145(3):615-23. doi: 10.1007/s10549-014-2983-x. Epub 2014 May 13. Breast Cancer Res Treat. 2014. PMID: 24820412

6

HER2 status in colorectal cancer: its clinical significance and the relationship between HER2 gene amplification and expression.

Seo AN, Kwak Y, Kim DW, Kang SB, Choe G, Kim WH, Lee HS. Seo AN, et al. PLoS One. 2014 May 30;9(5):e98528. doi: 10.1371/journal.pone.0098528. eCollection 2014. PLoS One. 2014. PMID: 24879338 Free PMC article.

7

Alu and LINE-1 hypomethylation is associated with HER2 enriched subtype of breast cancer.

Park SY, Seo AN, Jung HY, Gwak JM, Jung N, Cho NY, Kang GH. Park SY, et al. Among authors: seo an. PLoS One. 2014 Jun 27;9(6):e100429. doi: 10.1371/journal.pone.0100429. eCollection 2014. PLoS One. 2014. PMID: 24971511 Free PMC article.

8

MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.

Gwak JM, Kim HJ, Kim EJ, Chung YR, Yun S, Seo AN, Lee HJ, Park SY. Gwak JM, et al. Among authors: seo an. Breast Cancer Res Treat. 2014 Aug;147(1):39-49. doi: 10.1007/s10549-014-3069-5. Epub 2014 Aug 3. Breast Cancer Res Treat. 2014. PMID: 25086633

9

FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer.

Seo AN, Jin Y, Lee HJ, Sun PL, Kim H, Jheon S, Kim K, Lee CT, Chung JH. Seo AN, et al. Virchows Arch. 2014 Nov;465(5):547-58. doi: 10.1007/s00428-014-1634-2. Epub 2014 Aug 3. Virchows Arch. 2014. PMID: 25086725

10

Correlations between molecular subtypes and pathologic response patterns of breast cancers after neoadjuvant chemotherapy.

Lee HJ, Song IH, Seo AN, Lim B, Kim JY, Lee JJ, Park IA, Shin J, Yu JH, Ahn JH, Gong G. Lee HJ, et al. Among authors: seo an. Ann Surg Oncol. 2015 Feb;22(2):392-400. doi: 10.1245/s10434-014-4054-2. Epub 2014 Sep 6. Ann Surg Oncol. 2015. PMID: 25192679

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters